Detalhe da pesquisa
1.
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.
Gynecol Oncol
; 154(2): 441-448, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118141
2.
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448.
Gynecol Oncol
; 161(1): 328-329, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33551198
3.
Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" [Gynecol. Oncol. 154 (2019) 441-448].
Gynecol Oncol
; 157(2): 558-559, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087992
4.
Immunohistochemical expression of heparanases 1 and 2 in benign tissue and in invasive neoplasia of the endometrium: a case-control study.
Int J Gynecol Cancer
; 25(2): 269-78, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25423319
5.
Expression of CK7 and CDKN2 in Cervical Intraepithelial Neoplasia and Correlation with Clinical Outcome.
Anticancer Res
; 38(12): 6673-6681, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504376